- Home
- Companies
- usa oklahoma
- testing services targeting to preclinical studies
Refine by
Testing Services Targeting To Preclinical Studies Suppliers Serving Usa Oklahoma
74 companies found
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
Neuromyelitis optica (NMO) is an neurological autoimmune condition classified as a rare disease. Because of this classification, NMO lacks effective treatment options, since it is not of primary interest to the pharmaceutical industry. However, ...
based inNew York, NEW YORK (USA)
IN8bio was founded in 2016 with the mission of developing novel therapies to address cancer. The company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T-cell product ...
based inLa Jolla, CALIFORNIA (USA)
Ankasa is developing ART352-L as a novel regenerative medicine. Successful development of ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries and provide safe and effective enhancement of ...
based inPasadena, CALIFORNIA (USA)
LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...
Pre-clinical studies showed that LB-100 alone inhibits a spectrum of human cancers but when combined with standard cytotoxic drugs and/or radiation, LB-100 potentiates their effectiveness against hematologic and solid tumor cancers without enhancing ...
based inFremont, CALIFORNIA (USA)
EnColl Corporation, established in 1994, is a California corporation that develops, manufactures and markets Type-I collagen-based products. EnColl uses its patented technology for the preparation of high purity and charge modified collagen (U.S. ...
based inSan Carlos, CALIFORNIA (USA)
Vaxcyte is a clinical-stage vaccine innovation company based in San Carlos, California with a unique ability to rapidly engineer, optimize and manufacture superior, high-fidelity vaccines at scale. We do this by re-engineering how highly complex ...
based inHerstal, BELGIUM
KiOmed Pharma, based in Belgium, is a biotech company that focuses on the development, manufacture and distribution of safe and effective medical devices based on KiOmedine CM-Chitosan, our innovative and exclusive animal-free bioresorbable ...
based inWaltham, MASSACHUSETTS (USA)
Thermedical is developing a proprietary thermal ablation therapy that can treat significantly larger tissue volumes using a single device than conventional technology. Thermedical is a privately held medical device company based in Waltham, ...
based inBerlin, GERMANY
iMouse GmbH, a Berlin-based company specializing in digital home cage monitoring solutions for preclinical research. Their flagship product, the iMouse system, aims to enhance objectivity, reduce human bias, and improve animal welfare in laboratory ...
iMouse GmbH offers a sophisticated AI-powered platform that is revolutionizing preclinical studies by providing digital biomarkers. This system processes video data of mice, converting their activities into comprehensive behavioral maps and charts. ...
based inUnion City, CALIFORNIA (USA)
Fibralign is an award-winning, commercial-stage, Stanford-spinout that designs, develops and produces novel therapeutic medical devices to address major unmet medical needs. Based in the San Francisco Bay Area, the company’s team has established GMP ...
Fibralign is developing a pipeline of compelling novel products which are based on its proprietary Nanoweave® scaffolding platform that can be tailored to address a wide range of high-value applications. Nanoweave technology provides the means ...
based inBozeman, MONTANA (USA)
Microbion is a clinical-stage pharmaceutical company developing a novel class of compounds for the treatment of difficult-to-treat infections, including chronic infections and antibiotic-resistant infections. Microbion is dedicated to developing ...
Cystic Fibrosis (CF) lung disease, which is estimated to affect more than 30,000 in the US and 70,000 worldwide1, is characterized by chronic bacterial infection and severe inflammation that leads to progressive deterioration in lung function. ...
based inLondon, UNITED KINGDOM
Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations. We ...
based inSyracuse, NEW YORK (USA)
Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions. Our multi-patented, ZetaMet technology is a ...
based inPhiladelphia, PENNSYLVANIA (USA)
A clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases Cabaletta Bio seeks to employ its specifically targeted CAAR (Chimeric AutoAntibody Receptor) T ...
PLA2R-CAART is being developed to treat patients with PLA2R-associated membranous nephropathy (MN), a B cell-mediated autoimmune disease that affects the kidneys. B cells produce autoantibodies, which are believed to form immune ...
based inCambridge, MASSACHUSETTS (USA)
Abcam identifies, develops, and provides high-quality biological reagents and tools which are essential in a wide range of fields and applications including drug discovery, diagnostics and basic research. We supply the global life science community ...
based inCardiff, UNITED KINGDOM
Alesi Surgical was founded in 2009 to develop and commercialise products that improve the safety, efficacy and outcomes of surgical procedures. The company is a spin-out from the Welsh Institute for Minimal Access Therapy (WIMAT), a leading surgical ...
Alesi Surgical and WIMAT are co-located and collaborate on research and development, testing, product design, pre-clinical evaluation and post-market clinical follow-up. This provides a unique level of access to experienced surgeons, surgical ...
based inLowell, MASSACHUSETTS (USA)
Diagnosys is an inventor-owned private company devoted to the field of ophthalmic electrophysiology. Founded in 1983 as Doran Instruments, this company invented the Maculoscope, a focal ERG system that is the predicate device for most of the ...
based inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
ArterioSorb is produced from the FDA approved polymer, PLLA, which is already universally approved for use in cardiovascular stents, sutures and orthopaedic applications. ArterioSorb is a tubular stent with closed-cell (with connectors for strength) ...
based inMississauga, ONTARIO (CANADA)
Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...
Mentanine®, supported by (cannabidiol “CBD” + IP formula) – molecules bond and synergistically attach to PPAR receptors allowing the formula to cross the blood-brain barrier (BBB) to target the central nervous ...
based inEspoo, FINLAND
A truly global company with a proudly Finnish background, Medix Biochemica has offices and manufacturing facilities all around the world. Partnering with us means getting access to international, industry-leading expertise, meaning you can get to ...
